INVO Bioscience, Inc. — Form D/A

INVO Bioscience, Inc. of SARASOTA, FL, a company, filed a Form D amendment with the SEC on 2020-07-15. The offering totals $3.5M, of which $3.5M was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (21)

NameRoleLocation
Michael J CampbellDirectorSandy Springs, GA
Kevin DoodyDirectorSarasota, FL
Michael J CampbellExecutive OfficerSandy Springs, GA
Debra T HoopesExecutive OfficerSarasota, FL
Rebecca MessinaDirectorSeal Beach, CA
Trent DavisDirectorFRISCO, TX
Michael CampbellExecutive OfficerNewport Beach, CA
Matthew SzotDirectorPonte Vedra, FL
Andrea GorenExecutive OfficerSarasota, FL
Steven ShumDirectorSarasota, FL
Steven ShumExecutive OfficerSarasota, FL
Barbara RyanDirectorSarasota, FL
Jeffrey SegalDirectorSarasota, FL
Steven T ShumDirectorMedford, MA
Robert J BowdringDirectorMedford, MA
Robert J BowdringExecutive OfficerMedford, MA
Kevin J DoodyDirectorMedford, MA
Kathleen T KarloffDirectorMedford, MA
Kathleen T KarloffExecutive OfficerMedford, MA
Claude J RanouxExecutive OfficerBeverly, MA
Kathleen J KarloffExecutive OfficerBeverly, MA

Other filings by this issuer (7)

FiledFormOfferingSold
2023-04-06D$3.0M$3.0M
2023-03-06D/A$500K$500K
2023-02-17D$500K$300K
2023-01-11D$3.5M$275K
2020-05-28D$3.5M$2.1M
2018-01-24D$1.5M$15K
2009-10-14D$545K$545K

More